Teng CM - Search Results

1

Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3.

Wu CC, Hwang TL, Liao CH, Kuo SC, Lee FY, Lee CY, Teng CM. Wu CC, et al. Among authors: teng cm. Thromb Haemost. 2002 Jun;87(6):1026-33. Thromb Haemost. 2002. PMID: 12083482

2

The role of PAR4 in thrombin-induced thromboxane production in human platelets.

Wu CC, Hwang TL, Liao CH, Kuo SC, Lee FY, Teng CM. Wu CC, et al. Among authors: teng cm. Thromb Haemost. 2003 Aug;90(2):299-308. doi: 10.1160/TH03-02-0103. Thromb Haemost. 2003. PMID: 12888878

3

The indazole derivative YD-3 inhibits thrombin-induced vascular smooth muscle cell proliferation and attenuates intimal thickening after balloon injury.

Peng CY, Pan SL, Guh JH, Liu YN, Chang YL, Kuo SC, Lee FY, Teng CM. Peng CY, et al. Among authors: teng cm. Thromb Haemost. 2004 Dec;92(6):1232-9. doi: 10.1160/TH04-04-0216. Thromb Haemost. 2004. PMID: 15583728

4

A potential role of YC-1 on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse models.

Pan SL, Guh JH, Peng CY, Chang YL, Cheng FC, Chang JH, Kuo SC, Lee FY, Teng CM. Pan SL, et al. Among authors: teng cm. Thromb Haemost. 2005 May;93(5):940-8. doi: 10.1160/TH04-03-0195. Thromb Haemost. 2005. PMID: 15886813

5

Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.

Liao CH, Cheng JT, Teng CM. Liao CH, et al. Among authors: teng cm. Eur J Pharmacol. 2005 Sep 5;519(1-2):158-67. doi: 10.1016/j.ejphar.2005.06.041. Eur J Pharmacol. 2005. PMID: 16112105

6

Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.

Wu CC, Teng CM. Wu CC, et al. Among authors: teng cm. Eur J Pharmacol. 2006 Sep 28;546(1-3):142-7. doi: 10.1016/j.ejphar.2006.07.004. Epub 2006 Jul 14. Eur J Pharmacol. 2006. PMID: 16890935

7

Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives.

Chen HS, Kuo SC, Teng CM, Lee FY, Wang JP, Lee YC, Kuo CW, Huang CC, Wu CC, Huang LJ. Chen HS, et al. Among authors: teng cm. Bioorg Med Chem. 2008 Feb 1;16(3):1262-78. doi: 10.1016/j.bmc.2007.10.070. Epub 2007 Oct 25. Bioorg Med Chem. 2008. PMID: 17988878

8

The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation.

Wu CC, Wu SY, Liao CY, Teng CM, Wu YC, Kuo SC. Wu CC, et al. Among authors: teng cm. Br J Pharmacol. 2010 Oct;161(3):643-58. doi: 10.1111/j.1476-5381.2010.00921.x. Br J Pharmacol. 2010. PMID: 20880402 Free PMC article.

9

Combined blockade of thrombin anion binding exosite-1 and PAR4 produces synergistic antiplatelet effect in human platelets.

Wu CC, Wang WY, Wei CK, Teng CM. Wu CC, et al. Among authors: teng cm. Thromb Haemost. 2011 Jan;105(1):88-95. doi: 10.1160/TH10-05-0305. Epub 2010 Nov 5. Thromb Haemost. 2011. PMID: 21057701

10

YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.

Wu CC, Ko FN, Kuo SC, Lee FY, Teng CM. Wu CC, et al. Among authors: teng cm. Br J Pharmacol. 1995 Oct;116(3):1973-8. doi: 10.1111/j.1476-5381.1995.tb16400.x. Br J Pharmacol. 1995. PMID: 8640334 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters